Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2 Communicated by Peter C. Nowell, February 28, 1983 ABSTRACT Transferrin is required by many cells for growth. Mitogen-induced T lymphocyte proliferation is dependent on the presence of both interleukin 2 (IL-2; T-cell growth factor) and transferrin, even though resting lymphocytes do not have receptors for either. Exposure to mitogen (phytohemagglutinin) alone is sufficient to induce transient appearance of IL-2 receptors on lymphocytes. Using monoclonal antibodies to the IL-2 receptor and to the transferrin receptor, we examined those signals required for transferrin receptor induction during T lymphocyte proliferation. Our study has revealed that (i) monocytes, or a monocyte substitute such as the phorbol ester tetradecanoylphorbol 13-acetate, are required for transferrin receptor expression after mitogen exposure; (ii) the presence of IL-2 receptors is necessary for transferrin receptor induction; (iii) antibody to the IL-2 receptor inhibits thymidine incorporation (DNA synthesis) in
lymphocytes, but only if administered before transferrin receptors have appeared; and (iv) antitransferrin receptor antibody inhibits DNA synthesis but has minimal effect on IL-2 receptor expression. Thus, IL-2 receptor induction leads to transferrin receptor induction and subsequent initiation of DNA synthesis. These data indicate that IL-2 stimulates T lymphocyte proliferation, at least in part, by induction of transferrin receptors on these cells.
Transferrin, the predominant serum iron-binding glycoprotein, is an essential component of serum-free media and is required for cell growth (1). Mitogen-induced lymphocyte proliferation is transferrin dependent, even though resting lymphocytes do not possess detectable transferrin receptors (2) (3) (4) . The signal responsible for transferrin receptor induction in these cells is not known.
T lymphocyte proliferation is known to be dependent on the presence of interleukin-2 (IL-2; T-cell growth factor) even though resting T cells lack receptors for this substance and do not respond to it (5-9). IL-2 has been shown to function via specific cell surface membrane receptors (10) . These receptors are induced in mitogen-stimulated cells which then can utilize IL-2 (in the presence of transferrin) to undergo many rounds of cell division. A relationship between IL-2 and transferrin in this phenomenon would appear likely.
Recently, monoclonal antibodies directed against the transferrin receptor and the IL-2 receptor have become available (11) (12) (13) (14) (15) (16) . In the present study, these reagents were used to characterize the kinetics of transferrin receptor appearance in mitogen-stimulated lymphocytes and to investigate the role of IL-2 in this process. Our results demonstrate an interdependence of receptors for IL-2 and transferrin because the presence of IL-2 receptors was required for the appearance of transferrin receptors on T cells, thereby permitting DNA synthesis. Fur- Culture Methods. Nonadherent cells were plated in 24-well microtiter plates (Costar) at 1 x 106/ml (2 ml per well). Phytohemagglutinin (PHA; Sigma) was used at a final concentration of 2 pkg/ml. Tetradecanoylphorbol 13-acetate (TPA) was used at a final concentration of 50 ng/ml (81 nM). Monoclonal antibody to the IL-2 receptor (anti-TAC, a gift from Thomas Waldmann, National Institutes of Health, Bethesda, MD) was used at a final ascites fluid dilution of 1:500. Monoclonal antibody to the transferrin receptor (42/6, a gift from Ian Trowbridge, Scripps Clinic, San Diego, CA) was used at a final concentration of 2 ,4g of purified antibody per ml. 42/6, a mouse IgA antibody, blocks the transferrin binding site and only minimally interferes with the binding of OKT9 (12) . OKT9 (Ortho Pharmaceutical, Raritan, NJ) is directed against the transferrin receptor (11, 13) but does not block transferrin binding (12) . In this study, OKT9 was used to detect receptors by immunofluorescence (see below). Anti-Leul, a pan T-cell reagent, was purchased from Becton Dickinson and used at a final concentration of 2.,ug/ml. All reagents were added to cultures as described in the text. Antibodies containing azide were dialyzed overnight at 40C against sterile phosphate-buffered saline containing 2% albumin and were filtered through 0.2-,Am filters before use. IL-2-dependent human T cells were cultured at 1 X 105/ml in RPMI 1640 containing 10% heat-inactivated huAbbreviations: IL-2, interleukin 2; PBL, peripheral blood lymphocytes; PHA, phytohemagglutinin; TPA, 12-0-tetradecanoylphorbol 13-acetate; FACS, fluorescence-activated cell sorter.
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Immunofluorescence. (Fig. 1A) . In the presence of PHA alone, cells never became transferrin-receptor positive (Fig. 1B) (Fig. 2) . When cells were treated with TPA alone, <25% were positive for both IL-2 and transferrin receptors 48 hr later (data not shown).
When transferrin-receptor expression was examined as a function of the cell cycle, receptor-positive cells were found in all phases, including Go/G1. Forty-eight hours after PHA addition, only 25% of GO/GI cells were transferrin-receptor positive but nearly all cells in S and G2+ M were receptor positive (84% and 88%, respectively; data not shown). PHA (2 ,g/ml) was added to the cultures at the initiation of the experiment and removed 3 hr later. IL-2 was added to half the cells at this point. The cultures were maintained for 3 days, and then receptor-positive cells and thymidine incorporation were determined. The stimulation index was calculated based on cells depleted of monocytes and kept in culture for 3 days with no further treatment (300-400 cpm). TAC was added 48 hr after PHA addition, DNA synthesis was decreased by only 20%. Thus, the ability of anti-TAC antibody to inhibit DNA synthesis was closely correlated with its ability to block transferrin receptor induction.
When antitransferrin receptor antibody (42/6) was added to these cultures, it consistently decreased DNA synthesis by approximately 75% (Table 5 ). These antibodies also appeared to modulate transferrin receptors off the surface of cells because the receptors could no longer be detected by OKT9. IL-2 receptor expression was not significantly decreased under these conditions. As a control, a pan T-cell antibody, anti-Leul, was added to cultures; it had no effect on either receptor expression or DNA synthesis. Thus, 42/6 antibody caused the disappearance of transferrin receptors from the cell surface and greatly inhibited DNA synthesis but left IL-2 receptors essentially unaffected.
To test the growth-regulating potential of the transferrin receptor in the presence of excess IL-2, we added antitransferrin receptor antibody (42/6) to cultures of IL-2-dependent T cells seeded at 1 x 105 cells per ml in the presence of excess partially purified IL-2. Cells were counted 3 days later and antitransferrin receptor antibody was found to have nearly completely inhibited their growth (by 68% and 81% in two experiments) (Table 6 ). Thus, even in the presence of excess IL-2, blockade of transferrin receptors inhibits the growth of IL-2-dependent T cells.
DISCUSSION
During the lectin-induced in vitro mitogenesis of PBL, receptors for IL-2 are generated. The present study demonstrates that this event is a prerequisite for the induction of transferrin receptors. Furthermore, the sequential induction of IL-2 receptor expression and transferrin receptor expression on the same cell is essential for DNA synthesis in this system. However, once transferrin receptors appear, the continued pres- ence of functional IL-2 receptors is not required for the cell to proceed with at least one round of DNA synthesis. The presence of monocytes or a monocyte-replacing factor [TPA (19) ] is absolutely required for the induction and maintenance of receptors for both IL-2 and transferrin (Table 1 ; Fig. 1 ). However, cells possessing these receptors will not synthesize DNA maximally in the absence of serum (Table 1) . Because transferrin can replace serum in mitogen-induced lymphocyte proliferation (3), the requirement for serum in our system is presumably a requirement for transferrin (a major serum component). The low level of DNA synthesis observed in the absence of serum (but in the presence of monocytes) may be dependent on transferrin produced and secreted by the cultured lymphocytes themselves (20, 21) . We have shown that anti-TAC antibody prevents the appearance of transferrin receptors on-PHA-stimulated lymphocytes. Similarly, Tsudo et al. (22) recently reported that addition of anti-TAC antibody to allo-activated T cells blocks the appearance of Ia antigen on these cells. Ia antigens are not normally present on resting T cells but appear after activation, probably during or after S phase of the cell cycle (23, 24) . AntiTac antibody has no effect on Ia antigen when added to T cells already expressing Ia, even though it appears to modulate the IL-2 receptor off the cell surface (22) . In our study, anti-Tac had no effect on transferrin receptors once the latter were detectable.
Recently, it has been proposed that IL-2 provides a signal necessary for activated lymphocytes to enter S phase (25) . Our data would support the idea that IL-2 production is part of a cascade of biochemical events initiated by mitogen (or antigen) stimulation. In this cascade, the appearance of functional IL-2 receptors is an early and pivotal step. After the appearance of IL-2 receptors, and in the presence of IL-2, transferrin receptor expression is induced and the cells enter S phase (Table 3) . If transferrin receptors are blocked, DNA synthesis and cell growth are inhibited. Furthermore, IL-2-dependent T cells also require transferrin receptor expression prior to DNA synthesis. Transferrin receptors have been shown to appear on cells before they enter S phase (4, 26, 27) . Our data demonstrate that transferrin receptors appear on those cells already possessing IL-2 receptors and are not lost by cells in S and G2+M; on the contrary, the vast majority (>80%) of cells in these two cycle phases still possess transferrin receptors.
The present results indicate that the growth-promoting effects of IL-2 on activated T cells are mediated via the induction of cell surface receptors for the serum glycoprotein transferrin. Transferrin plays an essential role in the maintenance of growth of continuous cell lines and is an essential component of serumfree media (1). Blockade of surface receptors for transferrin inhibits the growth of many cell lines (12, 27) and, as the present study indicates, DNA synthesis in mitogen-stimulated lymphocytes. The mechanism(s) by which transferrin exerts its ef-fects on growing cells is not known. Because the serum concentration of transferrin is quite high (4 mg/ml), it is not unreasonable that expression of transferrin receptors would be under complex metabolic control. By studying how IL-2 interaction with its receptor leads to transferrin receptor expression, we will be able to better understand how cell growth is normally regulated.
